Patent · US Active

Stabilizing camptothecin pharmaceutical compositions

US10456360B2 · kind B2 · utility

11Cited by

52References

31Claims

0Family size

Assignee

IPSEN BIOPHARM LIMITED · GB

Inventors

Daryl C. Drummond · Lincoln, US
Dmitri B. Kirpotin · San Francisco, US
Mark E. Hayes · Mill Valley, US
Charles O. Noble · San Francisco, US
Kevin Kesper · Watertown, US
Antoine M. Awad · Dedham, US
Douglas J. Moore · Newton, US
Andrew J. O'Brien · Franklin, US

Key dates

Filing date	Oct 15, 2016
Grant date	Oct 29, 2019
Priority date	—
Expiry date	Oct 15, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/907
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Irinotecan phospholipid liposomes with improved storage stability are provided, with related methods of treatment and manufacture. The irinotecan liposomes can have reduced formation of lyso-phosphatidylcholine (lyso-PC) during storage, and prior to administration to a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.